|
|
1377: Dynamic prediction of progression based on MRD in NDMM |
|
21 January |
13:30
13:45
|
SC Papendal
Room 14
|
|
|
|
1386: Real-World Bispecific Antibodies in Multiple Myeloma in the Netherlands (T-REX) |
|
21 January |
13:45
14:00
|
SC Papendal
Room 14
|
|
|
|
1391: No Added Value Beyond Two Fixed Doses of Tocilizumab in CAR-T Induced CRS |
|
21 January |
14:00
14:15
|
SC Papendal
Room 14
|
|
|
|
1385: Zanubrutinib in rare subgroup of AL amyloidosis |
|
21 January |
14:15
14:30
|
SC Papendal
Room 14
|
|